COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
COLL on Nasdaq
Shares outstanding
31,604,526
Price per share
$46.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
36,987,734
Total reported value
$1,294,013,273
% of total 13F portfolios
0%
Share change
+1,051,700
Value change
+$41,056,686
Number of holders
241
Price from insider filings
$46.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 16% $133,841,807 4,997,827 BlackRock, Inc. 31 Mar 2025
Rubric Capital Management LP 9.3% +29% $80,340,000 +$17,407,000 3,000,000 +28% Rubric Capital Management LP 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC 5.1% +4.8% $55,955,623 +$2,729,885 1,599,189 +5.1% Renaissance Technologies LLC 08 Sep 2025
Invesco Ltd. 4.9% -10% $48,100,835 -$5,793,481 1,584,871 -11% Invesco Ltd. 30 Jun 2025
PRINCIPAL GLOBAL INVESTORS 4.6% $44,508,457 1,466,506 PRINCIPAL GLOBAL INVESTORS 30 Jun 2025
Pacer Advisors, Inc. 1.1% -87% $11,222,855 -$46,153,054 419,076 -80% Pacer Advisors, Inc. 31 Mar 2025

As of 30 Sep 2025, 241 institutional investors reported holding 36,987,734 shares of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL). This represents 117% of the company’s total 31,604,526 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) together control 90% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 5,178,044 -3.1% 0% $181,179,760
Rubric Capital Management LP 8.9% 2,826,498 -10% 1.3% $98,899,165
EVENTIDE ASSET MANAGEMENT, LLC 7.6% 2,390,912 -9.5% 1.4% $83,653,116
VANGUARD GROUP INC 7% 2,226,378 -0.97% 0% $77,900,966
RENAISSANCE TECHNOLOGIES LLC 5.1% 1,599,189 +5.1% 0.07% $55,955,623
FULLER & THALER ASSET MANAGEMENT, INC. 4.8% 1,502,674 +5% 0.18% $52,578,565
PRINCIPAL FINANCIAL GROUP INC 4.1% 1,309,771 -11% 0.02% $45,828,887
STATE STREET CORP 4.1% 1,293,911 -4.5% 0% $45,273,946
Invesco Ltd. 4.1% 1,282,971 -19% 0.01% $44,891,155
JANUS HENDERSON GROUP PLC 2.9% 910,241 +94% 0.01% $31,830,414
GEODE CAPITAL MANAGEMENT, LLC 2.6% 836,381 +7.2% 0% $29,268,905
DIMENSIONAL FUND ADVISORS LP 2.6% 831,091 -3.5% 0.01% $29,078,391
GOLDMAN SACHS GROUP INC 2.5% 802,234 +239% 0% $28,070,168
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.5% 793,934 -0.66% 0.01% $27,779,750
MORGAN STANLEY 2.4% 767,420 +25% 0% $26,852,063
EMERALD ADVISERS, LLC 2% 639,694 -24% 0.72% $22,382,893
VICTORY CAPITAL MANAGEMENT INC 1.5% 479,672 -5.7% 0.01% $16,783,724
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 406,849 +5.4% 0% $14,235,647
EMERALD MUTUAL FUND ADVISERS TRUST 1.3% 395,661 -28% 0.71% $13,844,178
D. E. Shaw & Co., Inc. 1.2% 389,775 +91% 0.01% $13,638,227
NORTHERN TRUST CORP 1.2% 371,316 -2.5% 0% $12,992,347
LSV ASSET MANAGEMENT 1.1% 346,600 -0.94% 0.03% $12,128,000
Qube Research & Technologies Ltd 1% 320,559 +238% 0.02% $11,216,359
LOOMIS SAYLES & CO L P 1% 317,880 -5.7% 0.01% $11,122,621
ROYCE & ASSOCIATES LP 0.97% 306,140 +0.11% 0.11% $10,711,839

Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,091,949 $96,873,491 +$41,511,319 $46.30 27
2025 Q3 36,987,734 $1,294,013,273 +$41,056,686 $34.99 241
2025 Q2 35,739,346 $1,056,745,851 -$27,671,390 $29.57 221
2025 Q1 36,773,847 $1,097,284,609 -$11,471,996 $29.85 241
2024 Q4 37,138,457 $1,064,290,472 -$54,467,577 $28.65 238
2024 Q3 38,489,790 $1,486,827,407 -$25,778,054 $38.64 248
2024 Q2 39,660,571 $1,277,281,895 -$10,053,520 $32.20 229
2024 Q1 39,565,870 $1,535,798,999 +$15,800,408 $38.82 226
2023 Q4 39,202,475 $1,206,720,767 +$15,870,252 $30.78 190
2023 Q3 38,712,156 $865,246,259 -$10,117,275 $22.35 174
2023 Q2 39,246,501 $843,481,973 +$2,463,793 $21.49 177
2023 Q1 39,049,844 $936,805,999 +$74,091,480 $23.99 196
2022 Q4 36,094,328 $837,390,551 +$6,535,089 $23.20 174
2022 Q3 35,876,068 $574,780,379 -$19,538,698 $16.02 158
2022 Q2 36,430,591 $645,532,750 +$14,193,849 $17.72 152
2022 Q1 36,080,262 $733,927,682 +$6,776,837 $20.36 161
2021 Q4 35,805,022 $668,826,744 -$13,881,763 $18.68 152
2021 Q3 36,444,427 $719,484,752 -$39,361,775 $19.74 150
2021 Q2 37,987,862 $898,085,585 -$27,328 $23.64 155
2021 Q1 38,008,378 $900,688,845 +$32,135,922 $23.70 161
2020 Q4 37,131,836 $744,007,768 -$8,934,464 $20.03 135
2020 Q3 39,011,062 $812,260,717 +$4,160,811 $20.82 140
2020 Q2 37,020,602 $647,728,854 +$3,968,987 $17.50 149
2020 Q1 36,901,564 $602,550,993 +$85,027,216 $16.33 157
2019 Q4 31,512,474 $648,599,114 +$50,675,226 $20.58 134
2019 Q3 30,030,196 $344,731,286 -$4,710,643 $11.48 116
2019 Q2 30,820,855 $405,253,075 -$9,461,407 $13.15 127
2019 Q1 31,440,940 $476,061,688 -$37,383,003 $15.14 142
2018 Q4 33,763,313 $579,232,154 +$15,811,423 $17.17 119
2018 Q3 33,465,415 $491,620,289 +$14,683,142 $14.74 122
2018 Q2 31,032,309 $740,054,845 +$15,772,890 $23.85 131
2018 Q1 30,253,700 $772,956,896 +$49,280,895 $25.55 135
2017 Q4 28,485,885 $526,126,077 +$70,690,864 $18.46 99
2017 Q3 26,039,739 $273,144,788 +$14,140,125 $10.49 74
2017 Q2 24,547,432 $307,092,409 +$19,595,869 $12.51 69
2017 Q1 23,352,469 $234,899,241 +$9,397,867 $10.06 80
2016 Q4 23,305,863 $362,917,530 +$115,650,426 $15.57 86
2016 Q3 15,869,884 $305,753,967 +$28,932,707 $19.26 71
2016 Q2 14,623,227 $173,348,652 -$11,495,754 $11.85 73
2016 Q1 14,863,823 $269,759,000 +$54,374,659 $18.15 70
2015 Q4 11,882,728 $326,630,223 -$5,739,748 $27.50 58
2015 Q3 10,244,867 $226,510,468 +$24,645,746 $22.11 45
2015 Q2 9,280,769 $165,466,756 +$165,466,759 $17.84 45